MDK and polycystic ovary syndrome: Next, N6-methyladenosine (m6A) regulators (YTHDF1, RBM15, and METTL14) and cuproptosis-specific molecular (COL5A1, IL18BP, SLC12A5, MDK, and RXRG) were identified successively an optimal related to the occurrence risk of PCOS, with a comparative analysis of the diverse ML as well as evaluated error rates [15, 43].